Qube Research & Technologies (QRT)
NVAX icon

Qube Research & Technologies (QRT)’s Novavax NVAX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-138,980
Closed -$2.53M – 2837
2022
Q3 		$2.53M Buy
138,980
+92,529
+199% +$4.01M 0.02% 834
2022
Q2 		$2.39M Sell
46,451
-87,142
-65% -$4.51M 0.02% 744
2022
Q1 		$9.84M Buy
+133,593
New +$11.9M 0.08% 316
2021
Q3 		– Sell
-9,930
Closed -$2.11M – 2604
2021
Q2 		$2.11M Buy
+9,930
New +$1.82M 0.02% 677
2020
Q4 		– Sell
-5,153
Closed -$558K – 2088
2020
Q3 		$558K Buy
+5,153
New +$628K 0.01% 994

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVAX Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Novavax (NVAX) in Q4 2022, closing a stake of 138,980 shares — an estimated $2.53M sold.

Qube Research & Technologies (QRT) first reported a position in NVAX in Q3 2020 and held it in 5 quarters. The position peaked at $9.84M in Q1 2022. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 138,980 Novavax shares in Q4 2022, an estimated $2.53M.
  • Qube Research & Technologies (QRT) first reported a position in Novavax in Q3 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Novavax position peaked at $9.84M in Q1 2022.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.